[1]
|
A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial
Journal of Trace Elements in Medicine and Biology,
2021
DOI:10.1016/j.jtemb.2020.126659
|
|
|
[2]
|
Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial
Nutrition & Metabolism,
2018
DOI:10.1186/s12986-018-0297-4
|
|
|
[3]
|
Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol
BMJ Open,
2017
DOI:10.1136/bmjopen-2017-016914
|
|
|
[4]
|
The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial
Trials,
2017
DOI:10.1186/s13063-017-1979-3
|
|
|